T. Rowe Price Associates’s Coherent Inc COHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,368
| Closed | -$4.36M | – | 3102 |
|
|
2022
Q2 | $4.36M | Buy |
16,368
+1,507
| +10% | +$404K | ﹤0.01% | 1440 |
|
|
2022
Q1 | $4.06M | Sell |
14,861
-1,899
| -11% | -$497K | ﹤0.01% | 1496 |
|
|
2021
Q4 | $4.47M | Sell |
16,760
-7,726
| -32% | -$1.99M | ﹤0.01% | 1508 |
|
|
2021
Q3 | $6.12M | Sell |
24,486
-368
| -1% | -$92.3K | ﹤0.01% | 1487 |
|
|
2021
Q2 | $6.57M | Sell |
24,854
-1,814
| -7% | -$477K | ﹤0.01% | 1465 |
|
|
2021
Q1 | $6.74M | Sell |
26,668
-51,116
| -66% | -$11.3M | ﹤0.01% | 1436 |
|
|
2020
Q4 | $11.7M | Sell |
77,784
-143,899
| -65% | -$18.4M | ﹤0.01% | 1330 |
|
|
2020
Q3 | $24.6M | Sell |
221,683
-125,193
| -36% | -$15.2M | ﹤0.01% | 1096 |
|
|
2020
Q2 | $45.4M | Sell |
346,876
-70,055
| -17% | -$9.17M | 0.01% | 882 |
|
|
2020
Q1 | $44.4M | Sell |
416,931
-1,717
| -0.4% | -$240K | 0.01% | 824 |
|
|
2019
Q4 | $69.6M | Sell |
418,648
-2,945
| -0.7% | -$456K | 0.01% | 786 |
|
|
2019
Q3 | $64.8M | Sell |
421,593
-114,723
| -21% | -$16.6M | 0.01% | 774 |
|
|
2019
Q2 | $73.1M | Sell |
536,316
-1,587,602
| -75% | -$214M | 0.01% | 744 |
|
|
2019
Q1 | $301M | Sell |
2,123,918
-496,315
| -19% | -$62.8M | 0.04% | 363 |
|
|
2018
Q4 | $277M | Sell |
2,620,233
-183,016
| -7% | -$23.5M | 0.05% | 349 |
|
|
2018
Q3 | $483M | Buy |
2,803,249
+103,089
| +4% | +$18.1M | 0.07% | 276 |
|
|
2018
Q2 | $422M | Buy |
2,700,160
+88,228
| +3% | +$14.9M | 0.06% | 291 |
|
|
2018
Q1 | $489M | Buy |
2,611,932
+360,788
| +16% | +$87M | 0.08% | 259 |
|
|
2017
Q4 | $635M | Buy |
2,251,144
+1,039,921
| +86% | +$290M | 0.1% | 215 |
|
|
2017
Q3 | $285M | Buy |
1,211,223
+812,438
| +204% | +$196M | 0.05% | 370 |
|
|
2017
Q2 | $89.7M | Sell |
398,785
-34,598
| -8% | -$7.95M | 0.02% | 634 |
|
|
2017
Q1 | $89.1M | Buy |
433,383
+6,226
| +1% | +$1.09M | 0.02% | 627 |
|
|
2016
Q4 | $58.7M | Buy |
427,157
+39,897
| +10% | +$4.85M | 0.01% | 758 |
|
|
2016
Q3 | $42.8M | Buy |
387,260
+76,500
| +25% | +$7.93M | 0.01% | 862 |
|
|
2016
Q2 | $28.5M | Sell |
310,760
-1,390
| -0.4% | -$128K | 0.01% | 978 |
|
|
2016
Q1 | $28.7M | Buy |
312,150
+134,390
| +76% | +$10.4M | 0.01% | 968 |
|
|
2015
Q4 | $11.6M | Buy |
177,760
+8,560
| +5% | +$528K | ﹤0.01% | 1248 |
|
|
2015
Q3 | $9.26M | Sell |
169,200
-1,300
| -0.8% | -$75.9K | ﹤0.01% | 1325 |
|
|
2015
Q2 | $10.8M | Sell |
170,500
-7,200
| -4% | -$462K | ﹤0.01% | 1325 |
|
|
2015
Q1 | $11.5M | Buy |
177,700
+3,750
| +2% | +$234K | ﹤0.01% | 1300 |
|
|
2014
Q4 | $10.6M | Sell |
173,950
-2,850
| -2% | -$169K | ﹤0.01% | 1309 |
|
|
2014
Q3 | $10.8M | Sell |
176,800
-4,700
| -3% | -$296K | ﹤0.01% | 1286 |
|
|
2014
Q2 | $12M | Buy |
181,500
+23,900
| +15% | +$1.48M | ﹤0.01% | 1275 |
|
|
2014
Q1 | $10.3M | Buy |
157,600
+10,900
| +7% | +$752K | ﹤0.01% | 1291 |
|
|
2013
Q4 | $10.9M | Buy |
146,700
+8,100
| +6% | +$545K | ﹤0.01% | 1266 |
|
|
2013
Q3 | $8.52M | Buy |
138,600
+4,700
| +4% | +$276K | ﹤0.01% | 1308 |
|
|
2013
Q2 | $7.37M | Buy |
+133,900
| New | +$7.45M | ﹤0.01% | 1323 |
|
Other funds holding COHR
WPC
IUHSA
WAM
IA
BTI
PTC
T. Rowe Price Associates's COHR Position: Q3 2022 in Review
T. Rowe Price Associates sold out of Coherent Inc (COHR) in Q3 2022, closing a stake of 16,368 shares — an estimated $4.36M sold.
T. Rowe Price Associates first reported a position in COHR in Q2 2013 and held it in 37 quarters. The position peaked at $635M in Q4 2017. 7 funds tracked by Wall St. Rank hold COHR as of Q3 2022.
- T. Rowe Price Associates reported no remaining Coherent Inc position as of Q3 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 16,368 Coherent Inc shares in Q3 2022, an estimated $4.36M.
- T. Rowe Price Associates first reported a position in Coherent Inc in Q2 2013 and held it in 37 quarters.
- T. Rowe Price Associates's Coherent Inc position peaked at $635M in Q4 2017.
- 7 funds tracked by Wall St. Rank held Coherent Inc as of Q3 2022.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.